Safety and Tolerability of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Safety Run-in Results from a Phase 2 StudyBarry Paul,Jiri Minarik,Francesca Cottini,Cristina Gasparetto,Jack Khouri,Mitul Gandhi,Jens Hillengass,Moshe Levy,Michaela Liedtke,Sudhir Manda,Irwindeep Sandhu,Douglas Sborov,Ivan Spicka,Saad Z. Usmani,Lin Gu,Michelle Robeson,Michael Murphy,Camille Renard,Christine Chen,Ludek PourBlood(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要